HealthWarehouse.com (HEWA) Stock Price, News & Analysis

Company Overview

HealthWarehouse.com (OTCMKTS:HEWA) operates as a U.S.-based online pharmacy offering prescription and over-the-counter medications directly to consumers. Licensed and regulated by the U.S. Drug Enforcement Administration and state boards of pharmacy, the company provides nationwide home delivery of a wide range of medications, including brand-name and generic prescriptions, specialty drugs, over-the-counter health and wellness products, pet medications, and medical supplies. HealthWarehouse.com leverages an in-house team of pharmacists and certified technicians to ensure accurate dispensing and to support patient counseling, refill reminders, and medication adherence programs.

Founded in 2013 and headquartered in Carson City, Nevada, HealthWarehouse.com has focused on leveraging e-commerce technology to simplify the pharmacy experience. The company’s online platform enables patients to upload prescriptions, manage refills, and access digital care resources securely. HealthWarehouse.com holds accreditation from the National Association of Boards of Pharmacy’s Verified Internet Pharmacy Practice Sites (VIPPS) program, reflecting its compliance with federal and state regulatory standards. By integrating automated dispensing systems and partnerships with major courier services, the company aims to offer competitive pricing, rapid processing, and reliable delivery across all 50 states.

HealthWarehouse.com serves a broad demographic of U.S. consumers seeking convenience, affordability, and personalized care in their medication management. Its product portfolio extends from chronic disease therapies—such as cardiovascular, diabetes, and respiratory treatments—to wellness items like supplements, skincare, and over-the-counter remedies. While the company has not publicly disclosed detailed executive biographies, it is guided by a management team with extensive experience in pharmacy operations, regulatory compliance, and digital retail. HealthWarehouse.com continues to expand its service offerings through patient education initiatives, telehealth partnerships, and investments in logistics infrastructure to support growing demand for online pharmacy solutions.

Key Stats

• Today's Range: $0.14 to $0.14
• 50-Day Range: $0.09 to $0.15
• 52-Week Range: $0.08 to $0.18
• Volume: N/A
• Average Volume: 2,701 shs
• Market Capitalization: $7.89 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

HealthWarehouse.com Stock Analysis - MarketRank™

HealthWarehouse.com scored higher than 26% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: N/A
• Analyst Rating: N/A

Consensus Rating

There is not enough analysis data for HealthWarehouse.com.

Earnings and Valuation

• Score: 0.0 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of HealthWarehouse.com is -13.80, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of HealthWarehouse.com is -13.80, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Short Interest

• Score: 5.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

0.01% of the float of HealthWarehouse.com has been sold short.

Short Interest Ratio / Days to Cover

HealthWarehouse.com has a short interest ratio ("days to cover") of 0.23, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in HealthWarehouse.com has recently decreased by 40.75%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

HealthWarehouse.com does not currently pay a dividend.

Dividend Growth

HealthWarehouse.com does not have a long track record of dividend growth.

News and Social Media

• Score: 3.1 / 5
• News Sentiment: N/A

News Sentiment

HealthWarehouse.com has a news sentiment score of 1.00. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.68 average news sentiment score of Computer and Technology companies.

News Coverage This Week

MarketBeat has tracked 1 news article for HealthWarehouse.com this week, compared to 0 articles on an average week.

Company Ownership

• Score: 0.7 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, HealthWarehouse.com insiders have not sold or bought any company stock.

Percentage Held by Insiders

24.50% of the stock of HealthWarehouse.com is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

0.02% of the stock of HealthWarehouse.com is held by institutions.

Company Calendar

• Last Earnings: 5/11/2026
• Today: 6/11/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Computer and Technology
• Industry: Internet Services - Delivery
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:HEWA
• CIK: 754813
• Web: www.healthwarehouse.com
• Phone: (800) 748-7001
• Fax: 888-870-2808
• Employees: 67
• Year Founded: 2007

Profitability

• EPS (Trailing Twelve Months): ($0.01)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: $260 thousand
• Net Margins: -0.68%
• Pretax Margin: -0.65%
• Return on Equity: -7.58%
• Return on Assets: -4.41%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 0.66
• Quick Ratio: 0.54

Sales & Book Value

• Annual Sales: $48.99 million
• Price / Sales: 0.16
• Cash Flow: $0.01 per share
• Price / Cash Flow: 9.98
• Book Value: ($0.06) per share
• Price / Book: -2.30

Miscellaneous

• Outstanding Shares: 57,190,000
• Free Float: 43,179,000
• Market Cap: $7.89 million
• Optionable: Not Optionable
• Beta: 0.25